Page last updated: 2024-09-03

etomoxir and Graft vs Host Disease

etomoxir has been researched along with Graft vs Host Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byersdorfer, CA; Ferrara, JL; Glick, GD; Goodell, S; Opipari, AW; Sandquist, S; Swanson, J; Tkachev, V1

Other Studies

1 other study(ies) available for etomoxir and Graft vs Host Disease

ArticleYear
Effector T cells require fatty acid metabolism during murine graft-versus-host disease.
    Blood, 2013, Oct-31, Volume: 122, Issue:18

    Topics: Animals; Blotting, Western; Bone Marrow Transplantation; Carnitine O-Palmitoyltransferase; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Female; Flow Cytometry; Graft vs Host Disease; Lymphocyte Activation; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocyte Subsets; Transcription Factors; Transplantation, Homologous

2013